Aaron Yarlas

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

BMC neurology

Journal of patient-reported outcomes

Patient related outcome measures

Journal of neurology

Optum

University of California, Los Angeles (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Optum

United States

Senior Scientist :: Patient Insights, QualityMetric

Optum

United States

Scientist :: QualityMetric

QualityMetric

United States

Associate Scientist :: Commercial Science

QualityMetric

United States

Senior Outcomes Research Associate :: Commercial Science

Grand Valley State University

United States

Assistant Professor :: Psychology

Ohio State University

United States

Postdoctoral Researcher :: Center for Cognitive Science

Education History

University of California, Los Angeles

United States

PHD :: Cognitive Psychology

Publications

T Michelle Brown, Montserrat Vera-Llonch, Chisom Kanu, Asia Sikora Kessler, Aaron Yarlas, Sheri E Fehnel
Cross-Sectional Quantitative Evaluation of a Novel Patient-Reported Outcome Measure in Familial Chylomicronemia Syndrome. Patient related outcome measures 15 (2024)
T Michelle Brown, Montserrat Vera-Llonch, Chisom Kanu, Asia Sikora Kessler, Aaron Yarlas, Sheri E Fehnel
Cross-Sectional Quantitative Evaluation of a Novel Patient-Reported Outcome Measure in Familial Chylomicronemia Syndrome. Patient related outcome measures 15 (2024)
Aaron Yarlas, Andrew Lovley, Duncan Brown, Montserrat Vera-Llonch, Sami Khella, Chafic Karam
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy. BMC neurology 23 (1) (2023)
Aaron Yarlas, Andrew Lovley, Duncan Brown, Montserrat Vera-Llonch, Sami Khella, Chafic Karam
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy. BMC neurology 23 (1) (2023)
Aaron Yarlas, Andrew Lovley, Duncan Brown, Montserrat Vera-Llonch, Sami Khella, Chafic Karam
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy. BMC neurology 23 (1) (2023)
Aaron Yarlas, Andrew Lovley, Duncan Brown, Montserrat Vera-Llonch, Sami Khella, Chafic Karam
The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy. BMC neurology 23 (1) (2023)
Aaron Yarlas, Andrew Lovley, Duncan Brown, Mark Kosinski, Montserrat Vera-Llonch
Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study. Journal of neurology (2021)
Aaron Yarlas
Editorial response to Aimo et al Quality-of-life assessment in amyloid transthyretin amyloidosis. European journal of clinical investigation 51 (11) (2021)
Aaron Yarlas, Michelle K White, Danielle G St Pierre, Jakob B Bjorner
The development and validation of a revised version of the Medical Outcomes Study Sleep Scale (MOS Sleep-R). Journal of patient-reported outcomes 5 (1) (2021)
Aaron Yarlas, Andrew Lovley, Kristen McCausland, Duncan Brown, Montserrat Vera-Llonch, Isabel Conceição, Chafic Karam, Sami Khella, Laura Obici, Márcia Waddington-Cruz
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR. Neurology and therapy 10 (2) (2021)
Aaron Yarlas, Mary Kaye Willian, Arpita Nag
The impact of clinical symptoms and endoscopic and histologic disease activity on health-related quality of life in patients with ulcerative colitis following treatment with multimatrix mesalazine. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 30 (7) (2021)
Aaron Yarlas, Morie A Gertz, Noel R Dasgupta, Laura Obici, Michael Pollock, Elizabeth J Ackermann, Andrew Lovley, Asia Sikora Kessler, Pankaj A Patel, Michelle K White, Spencer D Guthrie
Burden of hereditary transthyretin amyloidosis on quality of life. Muscle & nerve 60 (2) (2019)
Teresa Coelho, Aaron Yarlas, Marcia Waddington-Cruz, Michelle K White, Asia Sikora Kessler, Andrew Lovley, Michael Pollock, Spencer Guthrie, Elizabeth J Ackermann, Steven G Hughes, Chafic Karam, Sami Khella, Morie Gertz, Giampaolo Merlini, Laura Obici, Hartmut H Schmidt, Michael Polydefkis, P James B Dyck, Thomas H Brannagan Iii, Isabel Conceição, Merrill D Benson, John L Berk
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis. Journal of neurology 267 (4) (2019)
Mary Kaye Willian, Geert D'Haens, Aaron Yarlas, Ashish V Joshi
Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study. Journal of patient-reported outcomes 2 (2018)
Aaron Yarlas, Stephen M Maher, Martha S Bayliss, Andrew Lovley, Joseph C Cappelleri, Marco D DiBonaventura
Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review. Journal of patient-reported outcomes 2 (1) (2018)
Aaron Yarlas, Martha Bayliss, Joseph C Cappelleri, Stephen Maher, Andrew G Bushmakin, Lea Ann Chen, Alireza Manuchehri, Paul Healey
Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 27 (2) (2017)

Aaron Yarlas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Aaron Yarlas